Showing results (151-160 of 290) with videos related to

Sort By:
Pageof 29
Scientific Reports|November 26, 2020
Traumatic tracheobronchial injuries: incidence and outcome of 136.389 patients derived from the DGU traumaregisterDavid Schibilsky, Arne Driessen, William James White, et al.
Plant Physiology and Biochemistry : PPB|May 18, 2024
Seed endophytic bacterium Lysinibacillus sp. (ZM1) from maize (Zea mays L.) shapes its root architecture through modulation of auxin biosynthesis and nitrogen metabolismGaurav Pal, Samiksha Saxena, Kanchan Kumar, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 30, 2016
Transition from parenteral to oral treprostinil in pulmonary arterial hypertensionMurali M Chakinala, Jeremy P Feldman, Franz Rischard, et al.
The FEBS Journal|May 15, 2009
Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cordJianjun Zhai, Anna-Lena Ström, Renee Kilty, et al.
Geriatric Orthopaedic Surgery & Rehabilitation|April 10, 2013
Hip fracture in a patient with severe pulmonary hypertensionSusan M Friedman, R James White, Steven M Finkelstein, et al.
Pulmonary Circulation|October 5, 2020
Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolusDaniel Lachant, Christina Bach, Bennett Wilson, et al.
Journal of Managed Care & Specialty Pharmacy|February 14, 2018
Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United StatesCharles D Burger, A Burak Ozbay, Howard M Lazarus, et al.
Research Square|April 5, 2022
Feasibility & Preliminary Efficacy of Structured Programming and a Parent Intervention to Mitigate Accelerated Summer BMI Gain: A pilot studyR Glenn Weaver, Bridget Armstrong, Elizabeth Adams, et al.
Pulmonary Circulation|January 27, 2015
Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertensionIoana R Preston, Jeremy Feldman, James White, et al.
Annals of the American Thoracic Society|April 13, 2026
Rodatristat Ethyl Decreases Activity in Pulmonary Arterial Hypertension: Results from the ELEVATE-2 TrialDaniel J Lachant, Sandeep Sahay, Robert Block, et al.
Pageof 29